Report cover image

U.K. Atrial Fibrillation Devices Market

Publisher Fatpos Global
Published Jun 01, 2022
Length 120 Pages
SKU # FAGL17509967

Description

U.K. Atrial Fibrillation Devices Market

Introduction

Atrial fibrillation (AF) is a type of cardiac arrhythmia which is caused by irregular electrical activities in the atria. It may occur with no symptoms but the most common ones associated with it are palpitations, fainting, congestive chest pain or failure of the heart. The confirmation for AF is obtained by an electrocardiogram which exhibits an absence of the wave and irregular rate of ventricular contractions. These irregularities in the regular cardio electric impulses of the sino-atrial node are the result of interference from chaotic electric impulses generating from roots of pulmonary veins consequently leading to the conduction of an irregular heartbeat. Atrial fibrillation based on the severity of the condition is divided into three types namely paroxysmal (symptoms stop within 24 hours), persistent (symptoms continue for more than a week), and permanent (long term) atrial fibrillation. According to WHO, atrial fibrillation is the most common type of arrhythmia. This report offers detailed coverage of Atrial Fibrillation devices industry and main market trends. The report forecast U.K. Atrial Fibrillation devices market to grow to reach 2,691.6 million USD in 2020.

key impacts on the industry:
  • RAW MATERIAL CRUNCH
  • SHUTDOWN OF THE PLANTS
  • MATERIAL FLUCTUATIONS
Key Segmentations Cardiologists reported that they are treating increasing numbers of patients with paroxysmal and persistent AF
  • The cardiac rhythm management is expected to witness fastest market growth owing to the emergence of implantable cardiac monitors (ICMs) and worldwide adoption of other cardiac monitors such as holter monitor, event recorder, mobile cardiac telemetry (MCT) to monitor heart rhythms
Key Development Involvement of the biotech companies Product formulationsInvestment for improving content Price fluctuations Energy price impacting the overall industry

In May 2020, CardioFocus, Inc. received the U.S. Food and Drug Administration approval for the next generation HeartLight X3 Endoscopic Ablation System for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation.Allied industry Data The ardic arrhythmia market is allied to the Atrial fibrillation devices market. Atrial fibrillation (AF) is the most common cardiac arrhythmia, occurring in 1.5-2.0% of the general population. The presence of AF is associated with unfavourable prognosis.

Table of Contents

120 Pages
Chapter 1 Executive Summary
1.1 Business Trends
1.2 Country Trends
1.3 Atrial fibrillation devices market: COVID-19 Outbreak
Chapter 2 Introduction
2.1 Market Research Methodology
2.1.1 Research Process
2.1.2 Primary Research
2.1.3 Secondary Research
2.1.4 Data Collection Technique
2.1.5 Data Sources
2.2 Market Estimation Methodology
2.3 Years Considered for the Study
Chapter 3 Market Characteristics
3.1 Market Definition
Chapter 4 U.K. Atrial Fibrillation Devices Market - Industry Insights
4.1 U.K. Atrial Fibrillation Devices Market: Classification
4.2 Covid-19 impact on Global economy
4.3 Industry ecosystem Channel Analysis
4.4 Innovation and Sustainability
4.4.1 Innovations
4.4.2 Sustainability
Chapter 5 Macroeconomic Indicators
5.1 Macor Economic Outlook
Chapter 6 Recent Developments
6.1 Recent Developments
Chapter 7 Market Dynamics
7.1 Drivers
7.1.1 Increasing Adoption Of Closure Devices
7.1.2 Rise In Prevalence Of Atrial Fibrillation In Geriatric Population
7.2 Restraints
7.2.1 Recall of products
7.2.2 High Cost
7.3 Opportunities
7.3.1 INCREASING INVESTENT IN R&D
7.4 Market Trends
7.4.1 Trends
Chapter 8 Risk Analysis
8.1 Impact of recent rise of energy prices in Atrial fibrillation
Chapter 9 Market Analysis
9.1 Porter’s Analysis
9.1.1 Supplier Power
9.1.2 Buyer Power
9.1.3 Substitution Threat
9.1.4 Threat from New Entry
9.1.5 Competitive Rivalry
9.2 PESTEL Analysis
9.2.1 Political
9.2.2 Economic
9.2.3 Technological
Chapter 10 U.K. Atrial Fibrillation Devices Market
10.1 U.K. Atrial Fibrillation Devices
10.1.1 U.K. Atrial Fibrillation Devices Market Revenue (USD Million), 2016 – 2020
Chapter 11 U.K. Atrial Fibrillation Market Analysis Forecast
11.1 U.K. Atrial Fibrillation Market Analysis – Overview
11.2 Market Segmentation
11.2.1 U.K. Atrial Fibrillation Devices Market, by Device Type 2020 – 2031
11.2.1.1 Diagnostic and Monitoring Market, USD Millions, 2020-2031
11.2.1.1.1 Electrocardiogram (ECG)
11.2.1.1.2 Remote Cardiac Monitoring
11.2.1.1.3 Others
11.2.1.1 Therapeuticand Surgical Devices Market, USD Millions, 2020-2031
11.2.1.1.1 Cardiac and Assist Devices
11.2.1.1.2 Cardiac Rhythm Management Devices
11.2.1.1.3 Catheter
11.2.1.1.4 Left Atrial Appendage and Closure Devices
11.2.1.1.5 Others
11.2.2 U.K. Atrial Fibrillation Devices Market, by Disorder Type 2020 – 2031
11.2.2.1 Paroxysmal Atrial Fibrillation Devices Market, USD Millions, 2020-2031
11.2.2.2 Persistent Atrial Fibrillation Devices Market, USD Millions, 2020-2031
11.2.2.3 Permanent Atrial Fibrillation Devices Market, USD Millions, 2020-2031
11.2.2.4 Others Atrial Fibrillation Devices Market, USD Millions, 2020-2031
11.2.3 U.K. Atrial Fibrillation Devices Market, by End-User, 2020 – 2031
11.2.3.1 Hospitals Market, USD Millions, 2020-2031
11.2.3.2 Cardiac Labs Market, USD Millions, 2020-2031
11.2.3.3 Ambulatory Surgical Centers Market, USD Millions, 2020-2031
11.2.3.4 Others Market, USD Millions, 2020-2031
Chapter 12 U.K. Atrial Fibrillation Devices Market, by Region 2020 – 2031
12.1.1 U.K. Atrial Fibrillation Devices Market, by Region 2020 – 2031
_Toc119529453
Chapter 13 U.K. Atrial Fibrillation Devices Market by Players
13.1 U.K. Atrial Fibrillation Devices Market Revenue Share (%): Competitive Analysis, 2020
13.2 U.K. Atrial Fibrillation Devices Market: Key Player Overview
Chapter 14 Competitive Analysis
14.1 Abbott
14.1.1 Business Overview
14.1.2 Abbott Business Financials (USD Million)
14.1.3 Abbott Atrial Fibrillation Product Category, Type and Specification
14.1.4 Abott Main Business/Business Overview
14.2 Boston Scientific Corporation
14.2.1 Business Overview
14.2.2 Boston Scientific Corporation Business Financials (USD Million)
14.2.3 Boston Scientific Corporation Atrial fibrillation Product Category, Type and Specification
14.2.4 Boston Scientific Corporation Main Business/Business Overview
14.3 Biotronik
14.3.1 Business Overview
14.3.2 Biotronik Business Financials (USD Million)
14.3.3 Biotronik Atrial fibrillation Product Category, Type and Specification
14.3.4 Biotronik Main Business/Business Overview
14.4 Cardinal Health, Inc.
14.4.1 Business Overview
Mike Kaufmann
14.4.2 Cardinal Health, Inc.Business Financials (USD Million)
14.4.3 Cardinal Health, Inc. Atrial fibrillation Product Category, Type and Specification
14.4.4 Cardinal Health, Inc.Main Business/Business Overview
14.5 Medtronic Plc
14.5.1 Business Overview
14.5.2 Medtronic PLC Business Financials (USD Million)
14.5.3 Medtronic PLC Atrial fibrillation Product Category, Type and Specification
14.5.4 Medtronic PLC Main Business/Business Overview
14.6 W L Gore and Associates
14.6.1 Business Overview
14.6.2 W. L. Gore & Associates, Inc. Business Financials (USD Million)
14.6.3 W. L. Gore & Associates, Inc.Atrial fibrillation Product Category, Type and Specification
14.6.4 W. L. Gore & Associates, Inc. Main Business/Business Overview
14.7 Hansen Medical Inc
14.7.1 Business Overview
14.7.2 Hansen Medical Inc Business Financials (USD Million)
14.7.3 Hansen Medical IncAtrial fibrillation Product Category, Type and Specification
14.7.4 Hansen Medical Inc Main Business/Business Overview
14.8 Cardiofocus Inc.
14.8.1 Business Overview
14.8.2 Cardiofocus Inc. Business Financials (USD Million)
14.8.3 Cardiofocus Inc.Atrial fibrillation Product Category, Type and Specification
14.8.4 Cardiofocus Inc. Main Business/Business Overview
14.9 GE Healthcare
14.9.1 Business Overview
14.9.2 GE HealthcareBusiness Financials (USD Million)
14.9.3 GE Healthcare Atrial fibrillation Product Category, Type and Specification
14.9.4 GEHealthcare Main Business/Business Overview
14.10 Siemens Healthineers AG
14.10.1 Business Overview
Chapter 15 Market Research Findings & Conclusion
Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us